期刊文献+

血清降钙素原测定在慢性阻塞性肺疾病急性加重期治疗中的意义 被引量:38

The value of serum procalcitonin in treatment of acute exacerbations of chronic obstructive pulmonary disease
原文传递
导出
摘要 目的研究血清降钙素原(PCT)检测在慢性阻塞性肺疾病急性加重(AECOPD)患者治疗时抗生素使用中的临床意义。方法选取2004年5月至2006年12月间收治入院的AECOPD患者235例,随机分配为常规治疗组117例(A组)和PCT指导治疗组118例(B组),入院后即用荧光增强发射法检测血清PCT水平。在相同常规治疗基础上,A组由经治医师按照抗生素使用指南决定抗生素治疗方案,B组按照血清PCT水平决定是否使用抗生素,在血清PCT≥0.25ng/ml时,进行抗生素治疗,PCT〈0.25ng/ml时,不予抗生素治疗。观察两组患者的住院时间、临床有效率、住院费用及抗生素费用、抗生素使用率、住院病死率、1年随访期间AECOPD发生率及住院率。采用t检验、Mann—Whitney U检验及χ^2检验进行统计学分析。结果两组患者在临床有效率、住院病死率、住院时间及1年随访期间AECOPD发生率及住院率方面差异无统计学意义(P分别为0.635、0.768、0.884、0.747和0.727),PCT指导治疗组的抗生素费用、住院费用及抗生素使用率均低于常规治疗组(P分别为0.029,0.036和0.014)。结论AECOPD患者人院之初可以进行PCT水平检测以指导抗生素使用,能够降低抗生素使用率,减少用于抗生素使用的费用和总的住院费用。 Objective To evaluate the value of serum procalcitonin(PCT)on antibiotics use in treatment of acute exacerbations of chronic obstructive pulmonary disease(AECOPD). Method From May 2004 to December 2006, a total of 235 patients requiring hospitalization for AECOPD were randomly assigned into two groups: standard therapy group( group A, n = 117) and PCT-guided group( group B, n = 118). PCT levels of all patients were meastared after hospital admission by an amplified cryptate emission technology assay. On the base of similarly normal treatment, group A received antibiotics according to the attending physicians, and group B were treated with antibiotics according to serum PCF levels: antibiotic treatment was applied with PCT level ≥ 0.25 ng/ml and was discouraged with PCT level 〈 0.25 ng/mh Length of hospitalization, chnical efficacy, costs of hospitalization and antibiotics, rate of antibiotics use, hospital mortality, rate of exacerbation and rehospitalization within 1 year were observed. Analyses were performed by t test, Mann-Whitney U test or χ^2 test. Results Clinical efficacy, hospital mortality, length of hospitalization, rate of exacerbation and rehospitalization within 1 year were similar in two groups ( P = 0. 635,0. 768,0. 884,0. 747,0. 727) ; costs of antibiotics and hospitalization, rate of antibiotics use of PCT- guided group were lower than that of standard therapy group( P = 0. 029,0. 036, 0. 014). Conclusions PCT could be, used in treatment of AECOPD for antibiotic use after hospital admission, which may reduce antibiotic use and lower costs of antibiotic and hospitalization.
出处 《中华急诊医学杂志》 CAS CSCD 2008年第9期974-977,共4页 Chinese Journal of Emergency Medicine
关键词 降钙素原 肺疾病 慢性阻塞性 Pmcalcitonin(PCT) Pulmonary diseases, chronic obstructive
  • 相关文献

参考文献15

  • 1Zielinski J, Bednarek M, Gorecka D, et al. Increasing COPD awareness [J]. Eur Respir J,2006,27(4) :833-852.
  • 2Nanshan Z, Chen W, Wanzhen Y, et al. Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey[J]. Am J Respir Crit Care Med,2007,176(8) :753-760.
  • 3阴赪宏,王超,文艳,张淑文,王宝恩.降钙素原及其在脓毒症诊断中的应用[J].中华急诊医学杂志,2003,12(5):357-358. 被引量:40
  • 4龙威,邓星奇.降钙素原及其临床应用[J].国外医学(老年医学分册),2004,25(5):216-219. 被引量:19
  • 5中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南[J].中华内科杂志,2002,41(9):640-646. 被引量:999
  • 6Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial[J]. Lancet, 2004( 9409 ),363 : 600-607.
  • 7Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? [ J ]. Ettr Respir J, 2002,20 (Suppl) : 9S- 19S.
  • 8Wilkinson TM, Hurst JR, Perera WR, et al. Effect of interactions between lower airway bacterial and rbinoviral infection in exacerbations of COPD [ J]. Chest, 2006,129(2) :317-324.
  • 9Lindenauer PK,Pekow P, Gao S, et al. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease [J]. Ann Intern Med,2006,144(12) :894-903.
  • 10Tugrul S, Esen F, Celebi S, et al. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response [ J ]. Anaesth Intensive Care, 2002,30 ( 6 ) : 747-754.

二级参考文献53

  • 1Maire F, Heraud MC, Loriette Y, et al. The value of procalcitonin in neonatal infections.Arch Pediatr, 1999, 6: 503-509.
  • 2Schmidt M, Burchardi C, Sitter T, et al.Procalcitonin in patients undergoing chronic hemodialysis. Nephron, 2000, 84: 187-188.
  • 3Schwenger V, Sis J, BreltbartA, et al. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection,1998, 26: 274-276.
  • 4Gramm H J, Dollinger P, Beler W.Procalcltonin: a new marker of inflammation wirtsantwort Longitudinalstudien in patient wiht sepsis and pertontifis. Chir Gastroenterol,1995, 11: 51-54.
  • 5Zeni F, Viallon A, Assicot M, et al.Procalcitonin serum concentrations and severity of sepsis. Clin Inters Care, 1994, 5: 89-98.
  • 6Oberhoffer M, Vogelsang H, Russwurm S, et al. Outcome prediction by traditional and new markers of inflammation in patients with sepsis.Clin Chem Lab Med, 1999, 37: 363-368.
  • 7Endo S, Kasal T, Inada K. Evaluation of procalcitonin levels in patients with systemic inflammatory response syndrome as the diagnosis of infection and the severity of illness.Kansenshogaku/Zasshi, 1999, 73 : 197-204.
  • 8Yukioka H, Yoskida G Kurita S. Plasma procalcitonin in sensis and organ failure. Ann Acad Med Singapore, 2001, 30: 528-531.
  • 9Claeys R, Vinken S, Spapen H, et aj.Plasma procalcltonin and C-reactive protein in acute septic shock: clinical and biological correlates. Grit Care Med, 2002, 30: 757-762.
  • 10Karzai W, Oberhoffer M, Meier-Hellmann A.Procalcitonin--a new indicator of the systemic response to severe infections. Infection,1997, 25 : 329-334.

共引文献1141

同被引文献393

引证文献38

二级引证文献456

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部